Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease

References

• Lobbes MB, Kooi ME, Lutgens E, et al. Leukocyte counts, myeloperoxidase, and pregnancy-associated plasma protein a as biomarkers for cardiovascular disease: towards a multi-biomarker approach. Int J Vasc Med. 2010;2010:726207.
   PubMedGoogle Scholar
• Chen X, Ba Y, Ma L, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18:997–1006.
   PubMed Web of Science ®Google Scholar
• Lawrie CH, Gal S, Dunlop HM, et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol. 2008;141:672–675.
   PubMed Web of Science ®Google Scholar
• Kozomara A, Griffiths-Jones S. Griffiths-Jones S: miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42:D68–73.
   PubMed Web of Science ®Google Scholar
• Valadi H, Ekström K, Bossios A, et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007;9:654–659.
   PubMed Web of Science ®Google Scholar
• Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733–1741.
   PubMed Web of Science ®Google Scholar
• Villarroya-Beltri C, Gutierrez-Vazquez C, Sanchez-Cabo F, et al. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013;4:2980.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A. 2008;105:10513–10518.
   PubMed Web of Science ®Google Scholar
• Arita T, Ichikawa D, Konishi H, et al. Circulating long non-coding RNAs in plasma of patients with gastric cancer. Anticancer Res. 2013;33:3185–3193.
   PubMed Web of Science ®Google Scholar
• Yang M, Chen J, Su F, et al. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer. 2011;10:117.
   PubMed Web of Science ®Google Scholar
• Gallo A, Tandon M, Alevizos I, et al. The majority of microRNAs detectable in serum and saliva is concentrated in exosomes. PLoS One. 2012;7:e30679.
   PubMed Web of Science ®Google Scholar
• Hergenreider E, Heydt S, Treguer K, et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol. 2012;14:249.
   PubMed Web of Science ®Google Scholar
• Yuan A, Farber EL, Rapoport AL, et al. Transfer of microRNAs by embryonic stem cell microvesicles. PLoS One. 2009;4:e4722.
   PubMed Web of Science ®Google Scholar
• Akao Y, Iio A, Itoh T, et al. Microvesicle-mediated RNA molecule delivery system using monocytes/macrophages. Mol Ther. 2011;19:395–399.
   PubMed Web of Science ®Google Scholar
• Skog J, Würdinger T, Van Rijn S, et al. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol. 2008;10:1470–1476.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu D, Chen X, et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol Cell. 2010;39:133–144.
   PubMed Web of Science ®Google Scholar
• Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One. 2008;3:e3694.
   PubMed Web of Science ®Google Scholar
• Zernecke A, Bidzhekov K, Noels H, et al. Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal. 2009;2:ra81.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003–5008.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423–433.
   PubMed Web of Science ®Google Scholar
• Théry C. Exosomes: secreted vesicles and intercellular communications. F1000 Biol Rep. 2011;3.
   PubMedGoogle Scholar
• Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol. 2013;200:373–383.
   PubMed Web of Science ®Google Scholar
• Fritz JV, Heintz-Buschart A, Ghosal A, et al. Sources and functions of extracellular small RNAs in human circulation. Annu Rev Nutr. 2016;36:301–336.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Yoshioka Y, et al. Secretory mechanisms and intercellular transfer of microRNAs in living cells. J Biol Chem. 2010;285:17442–17452.
   PubMed Web of Science ®Google Scholar
• Pigati L, Yaddanapudi SCS, Iyengar R, et al. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One. 2010;5:e13515.
   PubMed Web of Science ®Google Scholar
• Turchinovich A, Weiz L, Langheinz A, et al. Characterization of extracellular circulating microRNA. Nucleic Acids Res. 2011;39:7223–7233.
   PubMed Web of Science ®Google Scholar
• Wang K, Zhang S, Weber J, et al. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res. 2010;38:7248–7259.
   PubMed Web of Science ®Google Scholar
• Maggi LB, Kuchenruether M, Dadey DYA, et al. Nucleophosmin serves as a rate-limiting nuclear export chaperone for the mammalian ribosome. Mol Cell Biol. 2008;28:7050–7065.
   PubMed Web of Science ®Google Scholar
• Nawa Y, Kawahara K-I, Tancharoen S, et al. Nucleophosmin may act as an alarmin: implications for severe sepsis. J Leukoc Biol. 2009;86:645–653.
   PubMed Web of Science ®Google Scholar
• Borer R, Lehner C, Eppenberger H, et al. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell. 1989;56:379–390.
   PubMed Web of Science ®Google Scholar
• Ohshima K, Inoue K, Fujiwara A, et al. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010;5:e13247.
   Web of Science ®Google Scholar
• Condorelli G, Latronico MVG, Cavarretta E. microRNAs in cardiovascular diseases: current knowledge and the road ahead. J Am Coll Cardiol. 2014;63:2177–2187.
   PubMed Web of Science ®Google Scholar
• D’Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31:2765–2773.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, De Rosa S, Fox H, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res. 2010;107:677–684.
   PubMed Web of Science ®Google Scholar
• Gupta SK, Bang C, Thum T. Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease. Circulation-Cardiovascular Genet. 2010;3:484–488.
   PubMed Web of Science ®Google Scholar
• Niu Y, Zhang L, Qiu H, et al. An improved method for detecting circulating microRNAs with S-Poly(T) plus real-time PCR. Sci Rep. 2015;5:15100.
   PubMed Web of Science ®Google Scholar
• Burgos KL, Javaherian A, Bomprezzi R, et al. Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing. RNA. 2013;19:712–722.
   PubMed Web of Science ®Google Scholar
• Sayed ASM, Xia K, Salma U, et al. Diagnosis, prognosis and therapeutic role of circulating miRNAs in cardiovascular diseases. Heart Lung Circ. 2014;23:503–510.
   PubMed Web of Science ®Google Scholar
• Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010;391:73–77.
   PubMed Web of Science ®Google Scholar
• Ji X, Takahashi R, Hiura Y, et al. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem. 2009;55:1944–1949.
   PubMed Web of Science ®Google Scholar
• D’Alessandra Y, Carena MC, Spazzafumo L, et al. Diagnostic potential of plasmatic microRNA signatures in stable and unstable angina. PLoS One. 2013;8:e80345.
   PubMed Web of Science ®Google Scholar
• Tsai P-C, Liao Y-C, Wang Y-S, et al. Serum microRNA-21 and microRNA-221 as potential biomarkers for cerebrovascular disease. J Vasc Res. 2013;50:346–354.
   PubMed Web of Science ®Google Scholar
• Ali Sheikh MS, Xia K, Li F, et al. Circulating miR-765 and miR-149: potential noninvasive diagnostic biomarkers for geriatric coronary artery disease patients. BioMed Res Int. 2015;2015:1–8.
   Google Scholar
• Sayed ASM, Xia K, Li F, et al. The diagnostic value of circulating microRNAs for middle-aged (40–60-year-old) coronary artery disease patients. Clinics. 2015;70:257–263.
   PubMed Web of Science ®Google Scholar
• Tijsen AJ, Creemers EE, Moerland PD, et al. MiR423-5p as a circulating biomarker for heart failure. Circ Res. 2010;106:1035–1039.
   PubMed Web of Science ®Google Scholar
• Wang G-K, Zhu J-Q, Zhang J-T, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31:659–666.
   PubMed Web of Science ®Google Scholar
• Wang K-J, Zhao X, Liu Y-Z, et al. Circulating MiR-19b-3p, MiR-134-5p and MiR-186-5p are promising novel biomarkers for early diagnosis of acute myocardial infarction. Cell Physiol Biochem. 2016;38:1015–1029.
   PubMed Web of Science ®Google Scholar
• Kondkar AA, Abu-Amero KK. Utility of circulating microRNAs as clinical biomarkers for cardiovascular diseases. Biomed Res Int. 2015;2015:1–10.
   Google Scholar
• Vegter EL, Van Der Meer P, De Windt LJ, et al. MicroRNAs in heart failure: from biomarker to target for therapy. Eur J Heart Fail. 2016;18:457–468.
   PubMed Web of Science ®Google Scholar
• Goretti E, Wagner DR, Devaux Y. miRNAs as biomarkers of myocardial infarction: a step forward towards personalized medicine? Trends Mol Med. 2014;20:716–725.
   PubMed Web of Science ®Google Scholar
• Moldovan L, Batte KE, Trgovcich J, et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18:371–390.
   PubMed Web of Science ®Google Scholar
• Jensen SG, Lamy P, Rasmussen MH, et al. Evaluation of two commercial global miRNA expression profiling platforms for detection of less abundant miRNAs. BMC Genomics. 2011;12:435.
   PubMed Web of Science ®Google Scholar
• Thum T, Catalucci D, Bauersachs J. MicroRNAs: novel regulators in cardiac development and disease. Cardiovasc Res. 2008;79:562–570.
   PubMed Web of Science ®Google Scholar
• Peng Y, Song L, Zhao M, et al. Critical roles of miRNA-mediated regulation of TGFβ signalling during mouse cardiogenesis. Cardiovasc Res. 2014;103:258–267.
   PubMed Web of Science ®Google Scholar
• Thum T, Gross C, Fiedler J, et al. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature. 2008;456:980–984.
   PubMed Web of Science ®Google Scholar
• Catalucci D, Gallo P, Condorelli G. MicroRNAs in cardiovascular biology and heart disease. Circ Cardiovasc Genet. 2009;2:402–408.
   PubMed Web of Science ®Google Scholar
• Kosaka N, Iguchi H, Ochiya T. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci. 2010;101:2087–2092.
   PubMed Web of Science ®Google Scholar
• Fichtlscherer S, Zeiher AM, Dimmeler S, et al. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases?. Arterioscler Thrombosis Vascular Biol. 2011;31:2383–2390.
   PubMed Web of Science ®Google Scholar
• McManus DD, Ambros V. Circulating MicroRNAs in cardiovascular disease. Circulation. 2011;124:1908–1910.
   PubMed Web of Science ®Google Scholar
• Creemers EE, Tijsen AJ, Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res. 2012;110:483–495.
   PubMed Web of Science ®Google Scholar
• Min P-K, Chan SY. The biology of circulating microRNAs in cardiovascular disease. Eur J Clin Invest. 2015;45:860–874.
   PubMed Web of Science ®Google Scholar
• Karakas M, Schulte C, Appelbaum S, et al. Circulating microRNAs strongly predict cardiovascular death in patients with coronary artery disease-results from the large AtheroGene study. Eur Heart J. 2017;38:516–523.
   PubMed Web of Science ®Google Scholar
• Schulte C, Molz S, Appelbaum S, et al. miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease. PLoS One. 2015;10:e0145930.
   PubMed Web of Science ®Google Scholar
• Gao H, Guddeti RR, Matsuzawa Y, et al. Plasma levels of microRNA-145 are associated with severity of coronary artery disease. PLoS One. 2015;10:e0123477.
   PubMed Web of Science ®Google Scholar
• Zhong JF, He Y, Chen WJ, et al. Circulating microRNA-19a as a potential novel biomarker for diagnosis of acute myocardial infarction. Int J Mol Sci. 2014;15:20355–20364.
   PubMed Web of Science ®Google Scholar
• Wang F, Long GW, Zhao CX, et al. Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med. 2013;11:222.
   Web of Science ®Google Scholar
• Białek S, Górko D, Zajkowska A, et al. Release kinetics of circulating miRNA-208a in the early phase of myocardial infarction. Kardiol Pol. 2015;73:613–619.
   PubMed Web of Science ®Google Scholar
• Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. 2008;79:581–588.
   PubMed Web of Science ®Google Scholar
• Economou EK, Oikonomou E, Siasos G, et al. The role of microRNAs in coronary artery disease: from pathophysiology to diagnosis and treatment. Atherosclerosis. 2015;241:624–633.
   PubMed Web of Science ®Google Scholar
• Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143.
   PubMed Web of Science ®Google Scholar
• Lerman A, Zeiher AM. Endothelial function: cardiac events. Circulation. 2005;111:363–368.
   PubMed Web of Science ®Google Scholar
• Fleissner F, Jazbutyte V, Fiedler J, et al. Short communication: asymmetric dimethylarginine impairs angiogenic progenitor cell function in patients with coronary artery disease through a microRNA-21-dependent mechanism. Circ Res. 2010;107:138–143.
   PubMed Web of Science ®Google Scholar
• Weber M, Baker MB, Moore JP, et al. MiR-21 is induced in endothelial cells by shear stress and modulates apoptosis and eNOS activity. Biochem Biophys Res Commun. 2010;393:643–648.
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang K-C, Wu W, et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci U S A. 2011;108:10355–10360.
   PubMed Web of Science ®Google Scholar
• Li T, Cao H, Zhuang J, et al. Identification of miR-130a, miR-27b and miR-210 as serum biomarkers for atherosclerosis obliterans. Clin Chim Acta. 2011;412:66–70.
   PubMed Web of Science ®Google Scholar
• Ren JY, Zhang J, Xu N, et al. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One. 2013;8:e80738.
   Web of Science ®Google Scholar
• Ying D, Yang SH, Sha L, et al. Circulating microRNAs as novel diagnostic biomarkers for very early-onset (≤40 years) coronary artery disease. Biomed Environ Sci. 2016;29:545–554.
   PubMed Web of Science ®Google Scholar
• Kuhnert F, Mancuso MR, Hampton J, et al. Attribution of vascular phenotypes of the murine Egfl7 locus to the microRNA miR-126. Development. 2008;135:3989–3993.
   PubMed Web of Science ®Google Scholar
• Wagner J, Riwanto M, Besler C, et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol. 2013;33:1392–1400.
   PubMed Web of Science ®Google Scholar
• Jansen F, Yang X, Proebsting S, et al. MicroRNA expression in circulating microvesicles predicts cardiovascular events in patients with coronary artery disease. J Am Heart Assoc. 2014;3:e001249.
   PubMed Web of Science ®Google Scholar
• Loyer X, Potteaux S, Vion AC, et al. Inhibition of microRNA-92a prevents endothelial dysfunction and atherosclerosis in mice. Circ Res. 2014;114:434–443.
   PubMed Web of Science ®Google Scholar
• Suárez Y, Fernández-Hernando C, Yu J, et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A. 2008;105:14082–14087.
   PubMed Web of Science ®Google Scholar
• Bonauer A, Carmona G, Iwasaki M, et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science. 2009;324:1710–1713.
   PubMed Web of Science ®Google Scholar
• Niculescu LS, Simionescu N, Sanda GM, et al. MiR-486 and miR-92a identified in circulating HDL discriminate between stable and vulnerable coronary artery disease patients. PLoS One. 2015;10:e0140958.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423–433.
   PubMed Web of Science ®Google Scholar
• Tabet F, Vickers KC, Cuesta Torres LF, et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun. 2014;5:3292.
   PubMed Web of Science ®Google Scholar
• Liu W, Ling S, Sun W, et al., Liu W, Ling S, Sun W, Liu T, Li Y, Zhong G, Zhao D, Zhang P, Song J, Jin X, et al. Circulating microRNAs correlated with the level of coronary artery calcification in symptomatic patients. Sci Rep. 2015;5:16099.
   PubMed Web of Science ®Google Scholar
• Shan Z, Qin S, Li W, et al. An Endocrine genetic signal between blood cells and vascular smooth muscle cells: role of microRNA-223 in smooth muscle function and atherogenesis. J Am Coll Cardiol. 2015;65:2526–2537.
   PubMed Web of Science ®Google Scholar
• Androulidaki A, Iliopoulos D, Arranz A, et al. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity. 2009;31:220–231.
   PubMed Web of Science ®Google Scholar
• Nazari-Jahantigh M, Wei Y, Noels H, et al. MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest. 2012;122:4190–4202.
   PubMed Web of Science ®Google Scholar
• Du F, Yu F, Wang Y, et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2014;34:759–767.
   PubMed Web of Science ®Google Scholar
• Wei Y, Zhu M, Corbalán-Campos J, et al. Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:796–803.
   PubMed Web of Science ®Google Scholar
• O’Connell RM, Kahn D, Gibson WSJ, et al. MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity. 2010;33:607–619.
   PubMed Web of Science ®Google Scholar
• Liu G, Friggeri A, Yang Y, et al. miR-147, a microRNA that is induced upon toll-like receptor stimulation, regulates murine macrophage inflammatory responses. Proc Natl Acad Sci U S A. 2009;106:15819–15824.
   PubMed Web of Science ®Google Scholar
• Hoekstra M, Van Der Lans CAC, Halvorsen B, et al. The peripheral blood mononuclear cell microRNA signature of coronary artery disease. Biochem Biophys Res Commun. 2010;394:792–797.
   PubMed Web of Science ®Google Scholar
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685–1695.
   PubMed Web of Science ®Google Scholar
• Fernández-Hernando C, Suárez Y, Rayner KJ, et al. MicroRNAs in lipid metabolism. Curr Opin Lipidol. 2011;22:86–92.
   PubMed Web of Science ®Google Scholar
• Krützfeldt J, Rajewsky N, Braich R, et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature. 2005;438:685–689.
   PubMed Web of Science ®Google Scholar
• Esau C, Davis S, Murray SF, et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 2006;3:87–98.
   PubMed Web of Science ®Google Scholar
• Elmen J, Lindow M, Schutz S, et al. LNA-mediated microRNA silencing in non-human primates. Nature. 2008;452:896–899.
   PubMed Web of Science ®Google Scholar
• Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010;327:198–201.
   PubMed Web of Science ®Google Scholar
• Moore KJ, Rayner KJ, Suárez Y, et al. The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. Annu Rev Nutr. 2011;31:49–63.
   PubMed Web of Science ®Google Scholar
• Motawae TM, Ismail MF, Shabayek MI, et al. MicroRNAs 9 and 370 association with biochemical markers in T2D and CAD complication of T2D. PLoS One. 2015;10:e0126957.
   PubMed Web of Science ®Google Scholar
• Liu H, Yang N, Fei Z, et al. Analysis of plasma miR-208a and miR-370 expression levels for early diagnosis of coronary artery disease. Biomed Rep. 2016;5:332–336.
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Drosatos K, Hiyama Y, et al. MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res. 2010;51:1513–1523.
   PubMed Web of Science ®Google Scholar
• Gao W, He H-W, Wang Z-M, et al. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis. 2012;11:55.
   PubMed Web of Science ®Google Scholar
• Taganov KD, Boldin MP, Chang K-J, et al. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103:12481–12486.
   PubMed Web of Science ®Google Scholar
• Yang K, He YS, Wang XQ, et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett. 2011;585:854–860.
   PubMed Web of Science ®Google Scholar
• Zhu N, Zhang D, Chen S, et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011;215:286–293.
   PubMed Web of Science ®Google Scholar
• Duisters RF, Tijsen AJ, Schroen B, et al. miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling. Circ Res. 2009;104: 170–178. 176p following 178.
   PubMed Web of Science ®Google Scholar
• Rayner KJ, Suárez Y, Dávalos A, et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science. 2010;328:1570–1573.
   PubMed Web of Science ®Google Scholar
• Rottiers V, Najafi-Shoushtari SH, Kristo F, et al. MicroRNAs in metabolism and metabolic diseases. Cold Spring Harb Symp Quant Biol. 2011;76:225–233.
   PubMedGoogle Scholar
• Sene A, Khan AA, Cox D, et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 2013;17:549–561.
   PubMed Web of Science ®Google Scholar
• Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res. 2007;100:1579–1588.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009;105:158–166.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Remaley AT. MicroRNAs in atherosclerosis and lipoprotein metabolism. Curr Opin Endocrinol Diabetes Obes. 2010;17:150–155.
   PubMed Web of Science ®Google Scholar
• Kuehbacher A, Urbich C, Zeiher AM, et al. Role of Dicer and Drosha for endothelial microRNA expression and angiogenesis. Circ Res. 2007;101:59–68.
   PubMed Web of Science ®Google Scholar
• Fasanaro P, D’Alessandra Y, Di Stefano V, et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem. 2008;283:15878–15883.
   PubMed Web of Science ®Google Scholar
• Wang J, Yan C-H, Li Y, et al. MicroRNA-31 controls phenotypic modulation of human vascular smooth muscle cells by regulating its target gene cellular repressor of E1A-stimulated genes. Exp Cell Res. 2013;319:1165–1175.
   PubMed Web of Science ®Google Scholar
• Satoh M, Takahashi Y, Tabuchi T, et al. Circulating toll-like receptor 4-responsive microRNA panel in patients with coronary artery disease: results from prospective and randomized study of treatment with renin-angiotensin system blockade. Clin Sci (Lond). 2015;128:483–491.
   PubMed Web of Science ®Google Scholar
• Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009;460:705–710.
   PubMed Web of Science ®Google Scholar
• Wei Y, Nazari-Jahantigh M, Neth P, et al. MicroRNA-126, −145, and −155: a therapeutic triad in atherosclerosis?. Arterioscler Thrombosis Vascular Biol. 2013;33:449–454.
   PubMed Web of Science ®Google Scholar
• Wei Y, Schober A, Weber C. Pathogenic arterial remodeling: the good and bad of microRNAs. Am J Physiol Heart Circ Physiol. 2013;304:H1050–9.
   PubMed Web of Science ®Google Scholar
• Weber M, Baker MB, Patel RS, et al. MicroRNA expression profile in CAD patients and the impact of ACEI/ARB. Cardiol Res Pract. 2011;2011:1–5.
   Google Scholar
• Liu X, Cheng Y, Yang J, et al. Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application. J Mol Cell Cardiol. 2012;52:245–255.
   PubMed Web of Science ®Google Scholar
• Leung A, Trac C, Jin W, et al. Novel long noncoding RNAs are regulated by angiotensin II in vascular smooth muscle cells. Circ Res. 2013;113:266–278.
   PubMed Web of Science ®Google Scholar
• Shan Z-X, Lin Q-X, Fu Y-H, et al. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Biochem Biophys Res Commun. 2009;381:597–601.
   PubMed Web of Science ®Google Scholar
• Limana F, Esposito G, D’Arcangelo D, et al. HMGB1 attenuates cardiac remodelling in the failing heart via enhanced cardiac regeneration and miR-206-mediated inhibition of TIMP-3. PLoS One. 2011;6:e19845.
   PubMed Web of Science ®Google Scholar
• Boštjančič E, Zidar N, Glavač D. MicroRNAs and cardiac sarcoplasmic reticulum calcium ATPase-2 in human myocardial infarction: expression and bioinformatic analysis. BMC Genomics. 2012;13:552.
   PubMed Web of Science ®Google Scholar
• Zhou J, Shao G, Chen X, et al. miRNA 206 and miRNA 574-5p are highly expression in coronary artery disease. Biosci Rep. 2016;36:e00295.
   Web of Science ®Google Scholar
• Liu F, Li R, Zhang Y, et al. Association of plasma MiR-17-92 with dyslipidemia in patients with coronary artery disease. Medicine. 2014;93:e98.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond). 2010;119:87–95.
   PubMed Web of Science ®Google Scholar
• Koshiol J, Wang E, Zhao Y, et al. Strengths and limitations of laboratory procedures for microRNA detection. Cancer Epidemiol Biomarkers Prev. 2010;19:907–911.
   PubMed Web of Science ®Google Scholar